Digoxin

   
Google
 
Web NewDrugInformation.com

Digoxin


Drug - Digoxin
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Digoxin
Multiple ingredients are in alphabetical order.

Strength - 0.25MG
The potency of the active ingredient(s), Digoxin. May repeat for multiple part products.

Applicant - CARACO
The firm name holding legal responsibility for Digoxin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 076363
The FDA assigned number to Digoxin. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Digoxin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jan 31, 2003
The date Digoxin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Digoxin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Digoxin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Caraco Pharmaceutical Laboratories Ltd
The full name of the firm holding legal responsibility for the new application of Digoxin.

Digoxin